title: Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry.
abstract: A method for the determination of the neuroactive compound N-n-propylnorapomorphine (NPA) in biological tissues is described. Isolation of NPA from serum or brain tissue was achieved via liquid-liquid extraction from phosphate-buffered tissue extract (0.25 M, pH 7.2) into ethyl acetate. The NPA, along with a [2H7]NPA analogue serving as internal standard, was converted to the corresponding bis(trifluoroacetyl) ester by treatment with excess trifluoroacetic anhydride at 75 degrees C. The electrophoric derivatives were analyzed by fused-silica capillary gas chromatography-mass spectrometry in the negative ion chemical ionization mode. Selected ion monitoring of the [M-CF3CO]- ions of derivatized NPA (m/z 390) and internal standard [2H7]NPA (m/z 397) permitted the quantitation of NPA in serum and brain samples obtained from rats treated with either free NPA or the prodrug methylenedioxy-NPA (MDO-NPA). Calibration was conducted down to a practical limit of assay sensitivity, at 0.50 ng NPA per ml of serum and 0.50 ng NPA per g of brain. The relative standard deviation for replicate serum samples spiked at 20 ng/ml was 4.2% (n = 5) and for brain samples at 10 ng/g, it was 3.6%. This method revealed differences in the free NPA brain/serum ratios in rats treated separately with the stereoisomers R-(-)-MDO-NPA and S-(+)-MDO-NPA.
authors.affiliation: Barnett Institute, Northeastern University, Boston, MA 02115.
authors.forename: T M
authors.initials: TM
authors.lastname: Trainor
authors.forename: P
authors.initials: P
authors.lastname: Vouros
authors.forename: P
authors.initials: P
authors.lastname: Lampen
authors.forename: J L
authors.initials: JL
authors.lastname: Neumeyer
authors.forename: R J
authors.initials: RJ
authors.lastname: Baldessarini
authors.forename: N S
authors.initials: NS
authors.lastname: Kula
mesh_terms: D000818:Animals; D000978:Antiparkinson Agents / Q000032:analysis* / Q000097:blood / Q000493:pharmacokinetics; D001058:Apomorphine / Q000031:analogs & derivatives* / Q000032:analysis / Q000097:blood / Q000493:pharmacokinetics; D001711:Biotransformation; D001923:Brain Chemistry / Q000187:drug effects*; D008401:Gas Chromatography-Mass Spectrometry; D007202:Indicators and Reagents; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012997:Solvents; D013237:Stereoisomerism
chemical_list: D000978:Antiparkinson Agents; D007202:Indicators and Reagents; D012997:Solvents; C009074:N-n-propylnorapomorphine; D001058:Apomorphine